Boussard & Gavaudan Investment Management LLP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is and the CUSIP is 462222AD2. A total of 43 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Boussard & Gavaudan Investment Management LLP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,231,870
-29.2%
5,305
-32.0%
0.61%
-13.0%
Q2 2023$7,386,472
-61.1%
7,805
-62.8%
0.70%
-60.7%
Q1 2023$18,982,317
+17.9%
21,000
+20.0%
1.78%
+0.2%
Q4 2022$16,097,17517,5001.78%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 127,800,000$128,518,0002.56%
WOLVERINE ASSET MANAGEMENT LLC 107,030,000$106,622,0001.15%
MACKAY SHIELDS LLC 24,472,000$24,283,0000.61%
SSI INVESTMENT MANAGEMENT LLC 6,945,000$6,865,0000.46%
ADVENT CAPITAL MANAGEMENT /DE/ 20,000,000$19,863,0000.36%
TENOR CAPITAL MANAGEMENT Co., L.P. 15,500,000$15,433,0000.35%
Magnetar Financial LLC 16,700,000$16,606,0000.23%
CAMDEN ASSET MANAGEMENT L P /CA 4,300,000$4,249,0000.14%
CAPSTONE INVESTMENT ADVISORS, LLC 18,700,000$18,571,0000.11%
RWC Asset Management LLP 2,500,000$2,497,0000.08%
View complete list of IONIS PHARMACEUTICALS INC shareholders